A detailed history of Private Advisor Group, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Private Advisor Group, LLC holds 43,787 shares of IONS stock, worth $1.59 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
43,787
Previous 46,426 5.68%
Holding current value
$1.59 Million
Previous $2.21 Million 20.71%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$40.06 - $51.86 $105,718 - $136,858
-2,639 Reduced 5.68%
43,787 $1.75 Million
Q2 2024

Aug 05, 2024

SELL
$36.45 - $47.7 $56,497 - $73,935
-1,550 Reduced 3.23%
46,426 $2.21 Million
Q1 2024

Apr 30, 2024

SELL
$42.03 - $53.55 $34,926 - $44,500
-831 Reduced 1.7%
47,976 $2.08 Million
Q4 2023

Feb 06, 2024

BUY
$43.39 - $51.63 $8,200 - $9,758
189 Added 0.39%
48,807 $2.47 Million
Q3 2023

Nov 02, 2023

BUY
$38.5 - $47.13 $30,338 - $37,138
788 Added 1.65%
48,618 $2.21 Million
Q2 2023

Aug 09, 2023

SELL
$34.73 - $43.33 $22,123 - $27,601
-637 Reduced 1.31%
47,830 $1.96 Million
Q1 2023

May 10, 2023

SELL
$33.58 - $41.2 $85,326 - $104,689
-2,541 Reduced 4.98%
48,467 $1.73 Million
Q4 2022

Jan 18, 2023

SELL
$37.12 - $46.52 $2.19 Million - $2.74 Million
-58,864 Reduced 53.58%
51,008 $0
Q3 2022

Oct 14, 2022

SELL
$36.54 - $48.66 $1.02 Million - $1.36 Million
-27,910 Reduced 20.26%
109,872 $4.86 Million
Q2 2022

Jul 13, 2022

SELL
$31.71 - $43.0 $608,388 - $824,998
-19,186 Reduced 12.22%
137,782 $5.1 Million
Q1 2022

May 12, 2022

BUY
$29.88 - $37.04 $1.23 Million - $1.53 Million
41,226 Added 35.62%
156,968 $5.81 Million
Q4 2021

Feb 10, 2022

BUY
$25.61 - $35.1 $1.83 Million - $2.51 Million
71,637 Added 162.42%
115,742 $3.52 Million
Q3 2021

Oct 14, 2021

BUY
$33.54 - $40.55 $693,070 - $837,925
20,664 Added 88.15%
44,105 $1.48 Million
Q2 2021

Aug 12, 2021

BUY
$34.54 - $47.25 $186,481 - $255,102
5,399 Added 29.92%
23,441 $935,000
Q1 2021

Apr 22, 2021

BUY
$42.51 - $63.78 $138,625 - $207,986
3,261 Added 22.06%
18,042 $811,000
Q4 2020

Apr 01, 2021

BUY
$45.3 - $60.27 $669,579 - $890,850
14,781 New
14,781 $836,000
Q3 2020

Nov 02, 2020

SELL
$47.45 - $62.95 $62,112 - $82,401
-1,309 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$46.85 - $61.05 $61,326 - $79,914
1,309 New
1,309 $77,000
Q2 2019

Aug 14, 2019

SELL
$62.09 - $86.14 $270,712 - $375,570
-4,360 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$52.92 - $81.17 $230,731 - $353,901
4,360 New
4,360 $354,000
Q4 2018

Feb 11, 2019

SELL
$43.37 - $59.54 $199,979 - $274,538
-4,611 Closed
0 $0
Q3 2018

Nov 01, 2018

BUY
$42.88 - $53.7 $197,719 - $247,610
4,611 New
4,611 $238,000
Q1 2018

May 09, 2018

SELL
$44.08 - $55.05 $197,522 - $246,679
-4,481 Closed
0 $0
Q4 2017

Feb 07, 2018

SELL
$50.3 - $64.39 $24,596 - $31,486
-489 Reduced 9.84%
4,481 $231,000
Q3 2017

Nov 13, 2017

SELL
$45.56 - $59.57 $6,013 - $7,863
-132 Reduced 2.59%
4,970 $274,000
Q2 2017

Aug 10, 2017

BUY
N/A
5,102
5,102 $263,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.16B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.